Search results
Results From The WOW.Com Content Network
The systems of the body most affected by chemotherapy drugs include visual and semantic memory, attention and motor coordination and executive functioning. [9] [10] These effects can impair a chemotherapy patient's ability to understand and make decisions regarding treatment, perform in school or employment and can reduce quality of life. [10]
“This is often amplified in women undergoing chemotherapy for breast cancer, with research showing that around 75% experience brain fog symptoms such as confusion, forgetfulness, slow thinking ...
You may have heard of ‘chemo brain;’ some chemo patients describe experiencing memory problems, difficulty concentrating, and a feeling of mental fogginess during or after chemotherapy.”
Using your brain to read a book, solve a puzzle, or learn to play an instrument, for example, allows for neurons to make new memories, which creates a feedback loop of maintaining brain health ...
Motor and autonomic symptoms are less frequent but possible. Symptoms may start days after the patient receives their first dose of chemotherapy, are dose dependent, and tend to improve after completion of treatment. However, in some cases, symptoms can persist six months or later following the completion of chemotherapy. [8]
Lomustine is also a lipid soluble, which allows it to permeate the blood brain barrier well. This quality made it a reasonable candidate for the chemotherapy of intrinsic brain tumors. Lomustine is administered orally in six-to-eight-week intervals and with nadirs at five weeks after administration due to its delayed myelosuppressive properties ...
Tip: Maca root, sage, ginkgo biloba and ginseng are natural herbs that may help with the brain fog and mood some women experience hormonal changes. The 9 Most Common Questions Women Over 40 Ask ...
Temozolomide is an alkylating agent used to treat serious brain cancers; most commonly as second-line treatments for astrocytoma and as the first-line treatment for glioblastoma. [4] [6] [7] Olaparib in combination with temozolomide demonstrated substantial clinical activity in relapsed small cell lung cancer. [8] It is available as a generic ...